Lola Koktysh[email protected]MRIQuantitative imaging biomarkers show promise for NASHQuantitative imaging biomarkers are a promising approach for evaluating normal biological or pathogenic processes, as well as response to treatment and intervention. One near-term clinical application is the assessment of nonalcoholic steatohepatitis (NASH), according to Lola Koktysh of ScienceSoft.March 6, 2017Page 1 of 1Top StoriesPractice ManagementNew MR safety codes provide additional reimbursement for radiologistsIn a new column, Erin Stephens of Healthcare Administrative Partners reviews the new CPT code changes for MR safety services.CTCT, MRI reveal hidden brain changes linked to increased fall riskWomens ImagingImaging societies, experts react to U.S. Supreme Court's ruling on Braidwood caseMRIDeep learning plus MRI predicts likelihood of postpartum hemorrhageWomens ImagingPersonal tragedies spur unity behind bill for diagnostic breast care
